Production (Stage)
Ultralife Corporation
ULBI
$5.46
-$0.07-1.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 173.28M | 164.46M | 165.15M | 168.95M | 168.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 173.28M | 164.46M | 165.15M | 168.95M | 168.66M |
| Cost of Revenue | 129.69M | 122.14M | 122.04M | 124.74M | 125.42M |
| Gross Profit | 43.59M | 42.31M | 43.12M | 44.21M | 43.23M |
| SG&A Expenses | 25.25M | 24.08M | 23.02M | 22.97M | 22.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 163.85M | 154.49M | 152.76M | 155.18M | 155.14M |
| Operating Income | 9.43M | 9.97M | 12.39M | 13.76M | 13.51M |
| Income Before Tax | 7.14M | 8.30M | 10.92M | 12.32M | 13.19M |
| Income Tax Expenses | 1.76M | 1.89M | 1.89M | 2.27M | 2.79M |
| Earnings from Continuing Operations | 5.38 | 6.41 | 9.03 | 10.05 | 10.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -98.00K | -97.00K | -35.00K | 13.00K | 29.00K |
| Net Income | 5.29M | 6.31M | 8.99M | 10.06M | 10.43M |
| EBIT | 9.43M | 9.97M | 12.39M | 13.76M | 13.51M |
| EBITDA | 13.97M | 14.12M | 16.33M | 17.70M | 17.42M |
| EPS Basic | 0.32 | 0.38 | 0.55 | 0.61 | 0.64 |
| Normalized Basic EPS | 0.27 | 0.31 | 0.36 | 0.41 | 0.45 |
| EPS Diluted | 0.32 | 0.38 | 0.54 | 0.60 | 0.63 |
| Normalized Diluted EPS | 0.26 | 0.31 | 0.36 | 0.41 | 0.45 |
| Average Basic Shares Outstanding | 66.46M | 66.22M | 65.93M | 65.54M | 65.11M |
| Average Diluted Shares Outstanding | 67.14M | 66.98M | 66.70M | 66.13M | 65.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |